OPTIMAL FELODIPINE DOSE WHEN COMBINED WITH METOPROLOL IN ARTERIAL-HYPERTENSION - A SWEDISH MULTICENTER STUDY WITHIN PRIMARY HEALTH-CARE

被引：14

作者：

BRUN, J

FROBERG, L

KRONMANN, P

OLSSON, LB

SKOOG, P

TYGESEN, G

BENGTSSON, C

SCHERSTEN, B

TIBBLIN, G

机构：

[1] UNIV GOTEBORG, DEPT PRIMARY HLTH CARE, REDBERGSVAGEN 6, S-41665 GOTHENBURG, SWEDEN

[2] UNIV UPPSALA, DEPT PRIMARY HLTH CARE, S-75105 UPPSALA, SWEDEN

[3] UNIV LUND, DEPT PRIMARY HLTH CARE, S-22101 LUND, SWEDEN

[4] PRIMARY HLTH CARE CTR, HUDIKSVALL, SWEDEN

[5] PRIMARY HLTH CARE CTR, HOGANAS, SWEDEN

[6] PRIMARY HLTH CARE CTR, SODERHAMN, SWEDEN

[7] PRIMARY HLTH CARE CTR, KRISTINEHAMN, SWEDEN

[8] PRIMARY HLTH CARE CTR, BOLLNAS, SWEDEN

[9] PRIMARY HLTH CARE CTR, LJUNGBY, SWEDEN

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1990年 / 15卷

关键词：

D O I：

10.1097/00005344-199015004-00021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S60 / S64

页数：5

相关论文

共 9 条

[1] FELODIPINE VERSUS HYDROCHLOROTHIAZIDE AS AN ADDITION TO A BETA-BLOCKER IN THE TREATMENT OF HYPERTENSION
BORGMASTARS, H
FORSEN, B
TUOMILEHTO, J
HELLEBO, R
WALLE, PO
NIELSEN, HM
NIELSEN, E
WINKEL, O
STEINESS, E
IBSEN, H
[J]. DRUGS, 1987, 34 : 136 - 138
[2] EDGAR B, 1987, CARDIOVASC DRUG THER, V1, P232
[3] MICROVASCULAR MECHANISMS INVOLVED IN CALCIUM-ANTAGONIST EDEMA FORMATION
GUSTAFSSON, D
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 : S121 - S131
[4] ANTIHYPERTENSIVE EFFECT OF FELODIPINE OR HYDRALAZINE WHEN ADDED TO BETA-BLOCKER THERAPY
HANSSON, L
DAHLOF, B
GUDBRANDSSON, T
HELLSING, T
KULLMAN, S
KUYLENSTIERNA, J
LEPPERT, J
MOLLER, B
SKOGSTROM, K
SVENSSON, A
SVENSSON, O
UGANDER, L
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 (01) : 94 - 101
[5] FELODIPINE VERSUS PRAZOSIN AS AN ADDITION TO A BETA-BLOCKER IN THE TREATMENT OF ESSENTIAL-HYPERTENSION - THE AUSTRALIAN MULTICENTER STUDY
JACKSON, B
MORGAN, TO
GIBSON, J
ANDERSON, A
[J]. DRUGS, 1987, 34 : 109 - 119
[6] KJELLSTROM T, 1988, ACTA CLIN BELG S12, V43, pP78
[7] VASCULAR SELECTIVITY OF FELODIPINE
LJUNG, B
[J]. DRUGS, 1985, 29 : 46 - 58
[8] THE POTENTIAL FOR ADDED BENEFITS WITH BETA-BLOCKERS AND CALCIUM-ANTAGONISTS IN TREATING CARDIOVASCULAR DISORDERS
NAYLER, WG
[J]. DRUGS, 1988, 35 : 1 - 8
[9] NILSSONEHLE P, 1988, J CARDIOVASC PHAR S6, V12, pS183